Medical Communications

Showing 15 posts of 6418 posts found.

Novo Nordisk to buy two pharma research companies

August 27, 2015 Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions

Novo Nordisk is to acquire two privately-held biopharmaceutical research companies specialising in diabetes, for undisclosed sums. Calibrium and MB2, formed …

Cally Clarkson joins GCI Health as first director of medical education

August 27, 2015 Medical Communications Cally Clarkson, GCI Health

GCI Health has appointed Cally Clarkson as its first ever director of medical education.  Cally is based in GCI Health’s …

Vicky Smith promoted to senior account executive at Liberation Unlimited

August 27, 2015 Medical Communications Vicki Smith, liberation unlimited

Liberation Unlimited has promoted Vicky Smith to senior account executive.Vicky joined Liberation Unlimited in 2013, and has since played an …
cml

NHS restriction of CML treatment in England criticised

August 27, 2015 Medical Communications, Sales and Marketing NHS, NICE, chronic myeloid leukaemia, leukaemia

Medical experts have criticised NHS cost regulators’ decision to limit the use of Ariad’s Iclusig (ponatinib) in the treatment of …

Takeda gets European MAA approval for ixazomib

August 21, 2015 Medical Communications, Research and Development (FDA/EMA/MHRA), FDA/EMA/MHRA, Takeda, ixazomib, multiple myeloma

Takeda has announced that the European Medicines Agency (EMA) has accepted its Marketing Authorisation Application (MAA) for ixazomib, an investigational …
novartis

Novartis buys rights to GSK MS drug for up to $1 billion

August 21, 2015 Medical Communications, Research and Development, Sales and Marketing GlaxoSmithKline, Novartis, multiple sclerosis, ofatumumab

Novartis has added to its burgeoning multiple sclerosis portfolio with the $300 million acquisition of all outstanding rights to GlaxoSmithKline’s …
lilly_corporate_hq

Lilly and Boehringer’s Jardiance diabetes drug reduces cardiovascular risks

August 21, 2015 Medical Communications, Research and Development Boehringer Ingelheim, Eli Lilly, diabetes drugs

Eli Lilly’s diabetes drug Jardiance (empagliflozin) has shown in a study to be the very first blood sugar lowering drug …
sun_pharma_hq

Sun Pharma gets FDA approval for acne treatment

August 21, 2015 Medical Communications, Research and Development, Sales and Marketing Sun Pharma. acne treatments, drug approvals

The FDA has approved Sun Pharma’s new acne treatment, Ximino.The Ximino (minocycline hydrochloride) extended-release capsules, which will be available in …
259612

Monique Levy joins Google’s healthcare advisory board

August 20, 2015 Medical Communications google

Monique Levy, vice president of digital innovation at healthcare data and analytics firm Decision Resources Group, is joining Google’s healthcare …
car_t-cells

Kite Pharma says trial death was unrelated to KTE-C19

August 18, 2015 Medical Communications, Research and Development CAR-T, cinical trials, kite pharma, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma

Kite has confirmed last week’s rumours that a patient had died during its Phase I/II trial for the KTE-C19 non-Hodgkin’s …
Google sign

Google to expand diabetes monitoring technology

August 14, 2015 Medical Communications blood sugar, diabetes, glucose, google, smart technology, wearable tech

Google is teaming up with the diabetes device maker DexCom to build a small and affordable sensor that could help …
tamzin_redston

Tamzin Redston joines Wave

August 14, 2015 Medical Communications Tamzin Redston, Wave communications

Tamzin Redston has been appointed programme director at Wave, the specialist medical education company.Tamzin joins Wave with a background of …
Code of Practice

Bayer’s complaint over ‘misleading’ Novartis eye drug claims upheld

August 14, 2015 Medical Communications Bayer, Eylea, Lucentis, Novartis, PMCPA, code of conduct

The industry’s code of conduct regulator has ruled in favour of Bayer in a dispute claims made by Novartis when …
gareth-thurston-web

Gareth Thurston joins Cello Health Consulting

August 12, 2015 Medical Communications Cello, Gareth Thurston, cello health

Cello Health has appointed Gareth Thurston as a consultant following his prior experience in pharmaceutical marketing. Gareth has over 20 …
Health secretary Jeremy Hunt

Price tags on medicine packs a “headline grabbing gimmick”

August 7, 2015 Manufacturing and Production, Medical Communications Drug pricing, Jeremy Hunt, NHS, adherence, compliance

Plans to include a price tag on prescription medicines in England worth more than £20 have been dismissed as a …
The Gateway to Local Adoption Series

Latest content